Jennison Associates’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-265,873
Closed -$7.19M 654
2025
Q2
$7.19M Sell
265,873
-734,486
-73% -$21.3M ﹤0.01% 398
2025
Q1
$29.7M Buy
1,000,359
+166,605
+20% +$6.35M 0.02% 279
2024
Q4
$33M Buy
833,754
+448,251
+116% +$17M 0.02% 282
2024
Q3
$13.1M Sell
385,503
-15,581
-4% -$438K 0.01% 373
2024
Q2
$8.69M Sell
401,084
-10,456
-3% -$220K 0.01% 394
2024
Q1
$9.12M Buy
411,540
+17,426
+4% +$425K 0.01% 404
2023
Q4
$10.8M Sell
394,114
-23,438
-6% -$566K 0.01% 380
2023
Q3
$9.32M Buy
+417,552
New +$10.7M 0.01% 371
2022
Q1
Sell
-664,828
Closed -$27.4M 709
2021
Q4
$27.4M Buy
664,828
+196,068
+42% +$8.66M 0.02% 312
2021
Q3
$21.8M Buy
468,760
+8,315
+2% +$363K 0.01% 350
2021
Q2
$18.4M Sell
460,445
-278,449
-38% -$11.9M 0.01% 379
2021
Q1
$39.7M Buy
+738,894
New +$42.6M 0.03% 249

Other funds holding VCYT

Jennison Associates's VCYT Position: Q3 2025 in Review

Jennison Associates sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 265,873 shares — an estimated $7.19M sold.

Jennison Associates first reported a position in VCYT in Q1 2021 and held it in 12 quarters. The position peaked at $39.7M in Q1 2021. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Jennison Associates reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Jennison Associates sold 265,873 Veracyte shares in Q3 2025, an estimated $7.19M.
  • Jennison Associates first reported a position in Veracyte in Q1 2021 and held it in 12 quarters.
  • Jennison Associates's Veracyte position peaked at $39.7M in Q1 2021.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Jennison Associates's 13F filing for Q3 2025, filed 30 Oct 2025.